9(1)(H) COMMENTARY: Maybe the CRTC Should Impose a Penetration Rate …
9(1)(h) COMMENTARY: Maybe the CRTC should impose a penetration rate …
Filed under: dual diagnosis treatment programs
ZoomerMedia's VP of television program distribution (the guy who deals directly with the BDUs), Tony Greco, told the panel of commissioners during the company's appearance that he had a file called “BDUs gone wild” as proof his carriers won't and don't …
{Source}
Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO …
Filed under: dual diagnosis treatment programs
Press Conference ASCO will feature this study in the 2013 ASCO Annual Meeting press program on Saturday, June 1 from 8 – 9 a.m. CDT. Title: Phase II double-blind, randomized study of selumetinib plus dacarbazine versus placebo plus DTIC as first-line …
{Source}